|
KMID : 0620920210530061036
|
|
Experimental & Molecular Medicine
2021 Volume.53 No. 6 p.1036 ~ p.1045
|
|
|
Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma
|
|
Kwon Eun-Kyung
Choi Young-Woo
Yoon Il-Hee
Won Ha-Kyeong
Sim So-Yoon
Lee Hee-Ra
Kim Hyoung-Su
Ye Young-Min
Shin Yoo-Seob
Park Hae-Sim
Ban Ga-Young
|
|
|
Abstract
|
|
|
|
Asthma is a chronic eosinophilic inflammatory disease with an increasing prevalence worldwide. Endocannabinoids are known to have immunomodulatory biological effects. However, the contribution of oleoylethanolamide (OEA) to airway inflammation remains to be elucidated. To investigate the effect of OEA, the expression of proinflammatory cytokines was measured by RT-qPCR and ELISA in airway epithelial (A549) cells. The numbers of airway inflammatory cells and cytokine levels in bronchoalveolar lavage fluid, airway hyperresponsiveness, and type 2 innate lymphoid cells (ILC2s) were examined in BALB/c mice after 4 days of OEA treatment. Furthermore, eosinophil activation after OEA treatment was evaluated by measuring cellular CD69 levels in eosinophils from human peripheral eosinophils using flow cytometry. OEA induced type 2 inflammatory responses in vitro and in vivo. OEA increased the levels of proinflammatory cytokines, such as IL-6, IL-8, and IL-33, in A549 cells. In addition, it also induced eosinophilic inflammation, the production of IL-4, IL-5, IL-13, and IL-33 in bronchoalveolar lavage fluid, and airway hyperresponsiveness. OEA increased the numbers of IL-5- or IL-13-producing ILC2s in a mouse model. Finally, we confirmed that OEA increased CD69 expression (an eosinophil activation marker) on purified eosinophils from patients with asthma compared to those from healthy controls. OEA may play a role in the pathogenesis of asthma by activating ILC2s and eosinophils.
|
|
|
KEYWORD
|
|
|
Biomarkers, Innate immune cells
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
    
|
|